Basic Information
| RNALocate ID: | RLID-D:11000389 |
| RNA Symbol: | hsa-miR-195-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-195-5p |
| RNA ID: | miRBase:MIMAT0000461 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11001987 | Exosome | Serum | 18589210 |
| RLID:11001988 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001989 | Exosome | Breast milk | 22211110 |
| RLID:11001990 | Exosome | Brain tissue | 23382797 |
| RLID:11001991 | Exosome | Plasma | 23663360 |
| RLID:11001992 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001993 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001994 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11001185 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-195-5p | Diffuse large b cell lymphoma | MNDR-E-MI-23669 |
| MNDR | hsa-miR-195-5p | Pheochromocytoma | MNDR-E-MI-23670 |
| MNDR | hsa-miR-195-5p | Paraganglioma | MNDR-E-MI-23671 |
| MNDR | hsa-miR-195-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-23672 |
| MNDR | hsa-miR-195-5p | Colorectal adenoma | MNDR-E-MI-23673 |
| MNDR | hsa-miR-195-5p | Oral squamous cell carcinoma | MNDR-E-MI-23674 |
| MNDR | hsa-miR-195-5p | Large cell neuroendocrine cancer | MNDR-E-MI-23675 |
| MNDR | hsa-miR-195-5p | Medulloblastoma | MNDR-E-MI-23676 |
| MNDR | hsa-miR-195-5p | B cell lymphoma of malt type | MNDR-E-MI-23677 |
| MNDR | hsa-miR-195-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-23678 |
| MNDR | hsa-miR-195-5p | Lymphoma | MNDR-E-MI-23679 |
| MNDR | hsa-miR-195-5p | Non-hodgkin lymphoma | MNDR-E-MI-23680 |
| MNDR | hsa-miR-195-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-23681 |
| MNDR | hsa-miR-195-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-23682 |
| MNDR | hsa-miR-195-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-23683 |
| MNDR | hsa-miR-195-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-23684 |
| MNDR | hsa-miR-195-5p | Her2-receptor positive breast cancer | MNDR-E-MI-23685 |
| MNDR | hsa-miR-195-5p | Triple negative breast cancer | MNDR-E-MI-23686 |
| MNDR | hsa-miR-195-5p | Niemann-pick disease type c | MNDR-E-MI-23687 |
| MNDR | hsa-miR-195-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-23688 |
| MNDR | hsa-miR-195-5p | Prostate cancer | MNDR-E-MI-23689 |
| MNDR | hsa-miR-195-5p | Hirschsprung disease | MNDR-E-MI-23690 |
| MNDR | hsa-miR-195-5p | Gastric cancer | MNDR-E-MI-23691 |
| MNDR | hsa-miR-195-5p | Alzheimer disease | MNDR-E-MI-23692 |
| MNDR | hsa-miR-195-5p | Attention deficit hyperactivity disorder | MNDR-E-MI-23693 |
| MNDR | hsa-miR-195-5p | Intracranial aneurysm | MNDR-E-MI-23694 |
| MNDR | hsa-miR-195-5p | Bladder cancer | MNDR-E-MI-23695 |
| MNDR | hsa-miR-195-5p | Esophageal carcinoma | MNDR-E-MI-23696 |
| MNDR | hsa-miR-195-5p | Sarcoma | MNDR-E-MI-23697 |
| MNDR | hsa-miR-195-5p | Dysautonomia familial | MNDR-E-MI-23698 |
| MNDR | hsa-miR-195-5p | Head and neck cancer | MNDR-E-MI-23699 |
| MNDR | hsa-miR-195-5p | Ataxia telangiectasia | MNDR-E-MI-23700 |
| MNDR | hsa-miR-195-5p | Cardiovascular disease | MNDR-E-MI-23701 |
| MNDR | hsa-miR-195-5p | Carotid stenosis | MNDR-E-MI-23702 |
| MNDR | hsa-miR-195-5p | Lung cancer | MNDR-E-MI-23703 |
| MNDR | hsa-miR-195-5p | Kawasaki disease | MNDR-E-MI-23704 |
| MNDR | hsa-miR-195-5p | Down syndrome | MNDR-E-MI-23705 |
| MNDR | hsa-miR-195-5p | Parkinson disease | MNDR-E-MI-23706 |
| MNDR | hsa-miR-195-5p | Niemann-pick disease | MNDR-E-MI-23707 |
| MNDR | hsa-miR-195-5p | Colonic adenomas | MNDR-E-MI-23708 |
| MNDR | hsa-miR-195-5p | Basal-like breast cancer | MNDR-E-MI-23709 |
| MNDR | hsa-miR-195-5p | Squamous cell carcinoma | MNDR-E-MI-23710 |
| MNDR | hsa-miR-195-5p | Thyroid cancer | MNDR-E-MI-23711 |
| MNDR | hsa-miR-195-5p | Pancreatic cancer | MNDR-E-MI-23712 |
| MNDR | hsa-miR-195-5p | Malignant melanoma | MNDR-E-MI-23713 |
| MNDR | hsa-miR-195-5p | Lesch-nyhan syndrome | MNDR-E-MI-23714 |
| MNDR | hsa-miR-195-5p | Gaucher disease | MNDR-E-MI-23715 |
| MNDR | hsa-miR-195-5p | Rectum adenocarcinoma | MNDR-E-MI-23716 |
| MNDR | hsa-miR-195-5p | Nephroblastoma | MNDR-E-MI-23717 |
| MNDR | hsa-miR-195-5p | Colon cancer | MNDR-E-MI-23718 |
| MNDR | hsa-miR-195-5p | Ischemic attack transient | MNDR-E-MI-23719 |
| MNDR | hsa-miR-195-5p | Colon adenocarcinoma | MNDR-E-MI-23720 |
| MNDR | hsa-miR-195-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-23721 |
| MNDR | hsa-miR-195-5p | Familial ovarian cancer | MNDR-E-MI-23722 |
| MNDR | hsa-miR-195-5p | Carcinoma ductal breast | MNDR-E-MI-23723 |
| MNDR | hsa-miR-195-5p | Invasive ductal carcinoma | MNDR-E-MI-23724 |
| MNDR | hsa-miR-195-5p | Glioblastoma | MNDR-E-MI-23725 |
| MNDR | hsa-miR-195-5p | Glioma | MNDR-E-MI-23726 |
| MNDR | hsa-miR-195-5p | Chordoma | MNDR-E-MI-23727 |
| MNDR | hsa-miR-195-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-23728 |
| MNDR | hsa-miR-195-5p | Epilepsy temporal lobe | MNDR-E-MI-23729 |
| MNDR | hsa-miR-195-5p | Osteosarcoma | MNDR-E-MI-23730 |
| MNDR | hsa-miR-195-5p | Liposarcoma | MNDR-E-MI-23731 |
| MNDR | hsa-miR-195-5p | Inclusion body myositis | MNDR-E-MI-23732 |
| MNDR | hsa-miR-195-5p | Breast carcinoma | MNDR-E-MI-23733 |
| MNDR | hsa-miR-195-5p | Meningioma | MNDR-E-MI-23734 |
| MNDR | hsa-miR-195-5p | Liver cancer | MNDR-E-MI-23735 |
| MNDR | hsa-miR-195-5p | Uterine cancer | MNDR-E-MI-23736 |
| MNDR | hsa-miR-195-5p | Gastric adenocarcinoma | MNDR-E-MI-23737 |
| MNDR | hsa-miR-195-5p | Cervical squamous cell carcinoma | MNDR-E-MI-23738 |
| MNDR | hsa-miR-195-5p | Lung squamous cell carcinoma | MNDR-E-MI-23739 |
| MNDR | hsa-miR-195-5p | Carcinoma lung non-small-cell | MNDR-E-MI-23740 |
| MNDR | hsa-miR-195-5p | Lung adenocarcinoma | MNDR-E-MI-23741 |
| MNDR | hsa-miR-195-5p | Adrenocortical cancer | MNDR-E-MI-23742 |
| MNDR | hsa-miR-195-5p | Thyroid carcinoma | MNDR-E-MI-23743 |
| MNDR | hsa-miR-195-5p | Bladder urothelial carcinoma | MNDR-E-MI-23744 |
| MNDR | hsa-miR-195-5p | Skin cancer | MNDR-E-MI-23745 |
| MNDR | hsa-miR-195-5p | Carcinoma renal cell | MNDR-E-MI-23746 |
| MNDR | hsa-miR-195-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-23747 |
| MNDR | hsa-miR-195-5p | Clear cell renal cell carcinoma | MNDR-E-MI-23748 |
| MNDR | hsa-miR-195-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-23749 |
| MNDR | hsa-miR-195-5p | Large cell carcinoma | MNDR-E-MI-23750 |
| MNDR | hsa-miR-195-5p | Cholangiocarcinoma | MNDR-E-MI-23751 |
| MNDR | hsa-miR-195-5p | Esophageal cancer | MNDR-E-MI-23752 |
| MNDR | hsa-miR-195-5p | Oncocytoma | MNDR-E-MI-23753 |
| MNDR | hsa-miR-195-5p | Lung small cell carcinoma | MNDR-E-MI-23754 |
| MNDR | hsa-miR-195-5p | Schizophrenia | MNDR-E-MI-23755 |
| MNDR | hsa-miR-195-5p | Encephalopathy bovine spongiform | MNDR-E-MI-23756 |
| MNDR | hsa-miR-195-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-23757 |
| MNDR | hsa-miR-195-5p | Testicular germ cell cancer | MNDR-E-MI-23758 |
| MNDR | hsa-miR-195-5p | Heart failure | MNDR-E-MI-23759 |
| MNDR | hsa-miR-195-5p | Fibromyalgia | MNDR-E-MI-23760 |
| MNDR | hsa-miR-195-5p | Adenoma | MNDR-E-MI-23761 |
| MNDR | hsa-miR-195-5p | Breast invasive carcinoma | MNDR-E-MI-23762 |
| MNDR | hsa-miR-195-5p | Hepatocellular carcinoma | MNDR-E-MI-23763 |
| MNDR | hsa-miR-195-5p | Embryonal cancer | MNDR-E-MI-23764 |
| MNDR | hsa-miR-195-5p | Familiar ovarian carcinoma | MNDR-E-MI-23765 |
| MNDR | hsa-miR-195-5p | B-cell lymphoma | MNDR-E-MI-23766 |
| MNDR | hsa-miR-195-5p | Rheumatoid arthritis | MNDR-E-MI-23767 |
| MNDR | hsa-miR-195-5p | T-cell leukemia | MNDR-E-MI-23768 |
| MNDR | hsa-miR-195-5p | Hodgkin lymphoma | MNDR-E-MI-23769 |
| MNDR | hsa-miR-195-5p | Ulcerative colitis | MNDR-E-MI-23770 |
| MNDR | hsa-miR-195-5p | Dementia vascular | MNDR-E-MI-23771 |
| MNDR | hsa-miR-195-5p | Acute myeloid leukemia | MNDR-E-MI-23772 |
| MNDR | hsa-miR-195-5p | Colorectal cancer | MNDR-E-MI-23773 |
| MNDR | hsa-miR-195-5p | Nasopharynx carcinoma | MNDR-E-MI-23774 |
| MNDR | hsa-miR-195-5p | Acute lymphocytic leukemia | MNDR-E-MI-23775 |
| MNDR | hsa-miR-195-5p | Uterine cervical neoplasms | MNDR-E-MI-23776 |
| MNDR | hsa-miR-195-5p | Cardiomegaly | MNDR-E-MI-23777 |
| MNDR | hsa-miR-195-5p | Nasopharyngeal cancer | MNDR-E-MI-23778 |
| MNDR | hsa-miR-195-5p | Prostatic neoplasms | MNDR-E-MI-23779 |
| MNDR | hsa-miR-195-5p | Aids dementia complex | MNDR-E-MI-23780 |
| MNDR | hsa-miR-195-5p | Hypersomnolence idiopathic | MNDR-E-MI-23781 |
| MNDR | hsa-miR-195-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-23782 |
| MNDR | hsa-miR-195-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-23783 |
| MNDR | hsa-miR-195-5p | Pancreatitis chronic | MNDR-E-MI-23784 |
| MNDR | hsa-miR-195-5p | Sarcopenia | MNDR-E-MI-23785 |
| MNDR | hsa-miR-195-5p | Stroke lacunar | MNDR-E-MI-23786 |
| MNDR | hsa-miR-195-5p | Breast cancer her3+ negative | MNDR-E-MI-23787 |
| MNDR | hsa-miR-195-5p | Duke A | MNDR-E-MI-23788 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO4 | Homo sapiens | RR00055975 |
TOP